Appointment of Non-Exec

Phytopharm PLC
05 June 2006


Company Contact:                                U.K. Investor Relations Contact:
Phytopharm plc                                  Financial Dynamics
Dr Richard Dixey                                David Yates / Ben Atwell
                                                [phone]
[phone]
Dr Daryl Rees
[phone]
www.phytopharm.com


                    Appointment of Non Executive Director


GODMANCHESTER, Cambridgeshire, U.K. (June 5 2006) - Phytopharm plc (LSE: PYM;
NASDAQBB: PHYOF; PHYOY) ('Phytopharm') announces the appointment with immediate
effect of Mr A D (Sandy) Morrison, former CEO of Lipton Ltd (a Unilever
subsidiary) as a Non-executive Board Director of Phytopharm.

Mr Morrison (aged 59) has a BSc (Hons) in applied chemistry (Strathclyde) and
has over 20 years experience in general and international management, global
supply chain and R&D. He was Chief Executive Officer of Lipton Ltd, the global
tea sourcing organization for Unilever with operations in six countries for five
years from 2000 to 2006. During Mr Morrison's period as CEO, substantial
operational & financial improvements were made to the Unilever global tea supply
chain and he also played a significant part in addressing issues in the
international tea trade. In the immediate years prior to 2000, Mr Morrison had
senior international food & beverage roles for Unilever outside the UK, in the
supply chain and in R&D, both at the Rotterdam head office and in the Unilever
food and beverage subsidiary in Australia.

Commenting on the appointment, Mr Gordon Stevens, Chairman of Phytopharm, said;
'the appointment of a person of this calibre and experience to the Board of
Phytopharm will provide an important asset to the Company and I am delighted
that Sandy will be joining us. This appointment begins a process of
restructuring of the Board and I look forward to the announcement of further
appointments in due course.'

There are no further details required to be disclosed under paragraph 9.6.13R of
the Listing Rules or Disclosure Rule 3.1.2R.


                                     -ENDS-

NOTES TO EDITORS


Phytopharm plc

Phytopharm is a pharmaceutical company with a plant extract division. The
pharmaceutical division is dedicated to the discovery and development of single
chemicals as prescription medicines and the plant extract division is focussed
on the development of plant extracts as functional foods and veterinary
products..


More information concerning Phytopharm's activities can be found on its web site
                          at http://www.phytopharm.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange